PIK3CA RELATED OVERGROWTH SPECTRUM
Clinical trials for PIK3CA RELATED OVERGROWTH SPECTRUM explained in plain language.
Never miss a new study
Get alerted when new PIK3CA RELATED OVERGROWTH SPECTRUM trials appear
Sign up with your email to follow new studies for PIK3CA RELATED OVERGROWTH SPECTRUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized pills target root cause of painful vascular growths
Disease control Recruiting nowThis trial is testing two different oral medications for people with abnormal, non-cancerous growths of blood or lymph vessels (vascular malformations). The goal is to see if a year of treatment can reduce patients' most bothersome symptoms and shrink the growths. The specific dr…
Matched conditions: PIK3CA RELATED OVERGROWTH SPECTRUM
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists seek genetic clues to rare overgrowth disorder
Knowledge-focused Recruiting nowThis study aims to learn more about Proteus syndrome, a rare condition that causes unusual and uneven growth of bones, skin, and other tissues. Researchers will observe up to 1,500 patients over time to understand the genetic causes, how symptoms change, and the disease's impact …
Matched conditions: PIK3CA RELATED OVERGROWTH SPECTRUM
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC